• 11943 Citations
  • 55 h-Index
1973 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Review article
1995

Design and testing of peptide-based cytotoxic T-cell-mediated immunotherapeutics to treat infectious diseases and cancer.

Chesnut, R. W., Sette, A., Celis, E., Wentworth, P., Kubo, R. T., Alexander, J., Ishioka, G., Vitiello, A. & Grey, H. M., 1995, In : Pharmaceutical biotechnology. 6, p. 847-874 28 p.

Research output: Contribution to journalReview article

20 Scopus citations

Synthetic antigenic peptides as a new strategy for immunotherapy of cancer.

Appella, E., Loftus, D. J., Sakaguchi, K., Sette, A. & Celis, E., Jan 1 1995, In : Biomedical peptides, proteins & nucleic acids : structure, synthesis & biological activity. 1, 3, p. 177-184 8 p.

Research output: Contribution to journalReview article

18 Scopus citations
2002

Challenges in the development of effective peptide vaccines for cancer

Buteau, C., Markovic, S. N. & Celis, E., Jan 1 2002, In : Mayo Clinic Proceedings. 77, 4, p. 339-349 11 p., 61787.

Research output: Contribution to journalReview article

51 Scopus citations
2004

T-cell epitope peptide vaccines

Elsawa, S. F., Rodeberg, D. A. & Celis, E., Oct 1 2004, In : Expert Review of Vaccines. 3, 5, p. 563-575 13 p.

Research output: Contribution to journalReview article

21 Scopus citations
2007

Immunogenicity of protein therapeutics and the interplay between tolerance and antibody responses

Barbosa, M. D. F. S. & Celis, E., Aug 1 2007, In : Drug Discovery Today. 12, 15-16, p. 674-681 8 p.

Research output: Contribution to journalReview article

41 Scopus citations

Toll-like receptor ligands energize peptide vaccines through multiple paths

Celis, E., Sep 1 2007, In : Cancer Research. 67, 17, p. 7945-7947 3 p.

Research output: Contribution to journalReview article

42 Scopus citations
2008

Multiple roles for CD4+ T cells in anti-tumor immune responses

Kennedy, R. & Celis, E., Apr 1 2008, In : Immunological Reviews. 222, 1, p. 129-144 16 p.

Research output: Contribution to journalReview article

254 Scopus citations

Peptide epitope identification for tumor-reactive CD4 T cells

Kobayashi, H. & Celis, E., Apr 1 2008, In : Current Opinion in Immunology. 20, 2, p. 221-227 7 p.

Research output: Contribution to journalReview article

40 Scopus citations
2012

TriVax-HPV: An improved peptide-based therapeutic vaccination strategy against human papillomavirus-induced cancers

Barrios, K. & Celis, E., Aug 1 2012, In : Cancer Immunology, Immunotherapy. 61, 8, p. 1307-1317 11 p.

Research output: Contribution to journalReview article

49 Scopus citations
2017

Cancer immunotherapy: moving forward with peptide T cell vaccines

Kumai, T., Fan, A., Harabuchi, Y. & Celis, E., Aug 2017, In : Current Opinion in Immunology. 47, p. 57-63 7 p.

Research output: Contribution to journalReview article

23 Scopus citations

Designing therapeutic cancer vaccines by mimicking viral infections

Sultan, H., Fesenkova, V. I., Addis, D., Fan, A. E., Kumai, T., Wu, J., Salazar, A. M. & Celis, E., Feb 1 2017, In : Cancer Immunology, Immunotherapy. 66, 2, p. 203-213 11 p.

Research output: Contribution to journalReview article

15 Scopus citations

Peptide vaccines in cancer — old concept revisited

Kumai, T., Kobayashi, H., Harabuchi, Y. & Celis, E., Apr 1 2017, In : Current Opinion in Immunology. 45, p. 1-7 7 p.

Research output: Contribution to journalReview article

37 Scopus citations